Form 4: Beta Bionics Executive Sells Shares
Insider Transaction (Form 4)
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc, sold 775 shares of common stock on September 14, 2026 for $15.52 per share.
Summary
- Open-market sale: disposed of 775 Common Stock at $15.52 ($12,028) on September 14, 2026; holds 86,382 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $12,028 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Mark Hopman — Officer (Chief Commercial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Open-market sale | Common Stock | 775 | $16 | $12.0K | 86,382 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Open-market sale (775 shares) |
Keywords
insider transaction, Form 4, BBNX, Beta Bionics, Inc., bearish, Mark Hopman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.